Company intelligence / Profile preview

Sonara Health

Dallas, Texas, United Statessonarahealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sonara Health’s platform enables remote, digitally supervised methadone dosing for opioid use disorder patients. Clinical results and published studies indicate increased patient satisfaction, higher retention rates, improved provider trust, and no reported adverse events across over 15,000 doses administered. Ongoing NIH/NIDA-funded research is evaluating further outcomes such as retention and cost-effectiveness.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy (digital adherence platform)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

methadone

Commercial

Indications: Opioid use disorder

Partnerships

National Institute on Drug Abuse (NIDA) – grant funding partner

Beyond the preview

Go deeper on Sonara Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonara Health.

Explore the full profile